196 related articles for article (PubMed ID: 25616794)
21. Protective Effect of a Synbiotic against Multidrug-Resistant Acinetobacter baumannii in a Murine Infection Model.
Asahara T; Takahashi A; Yuki N; Kaji R; Takahashi T; Nomoto K
Antimicrob Agents Chemother; 2016 May; 60(5):3041-50. PubMed ID: 26953197
[TBL] [Abstract][Full Text] [Related]
22. Synbiotic Effect of
Marsaux B; Van den Abbeele P; Ghyselinck J; Prioult G; Marzorati M; Bogićević B
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751149
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of viability Bifidobacterium animalis subsp. lactis LKM512 in dogs.
Nakamura A; Ohnishi Y; Shirotori K; Matsumoto M
Benef Microbes; 2015; 6(6):791-7. PubMed ID: 26322543
[TBL] [Abstract][Full Text] [Related]
24. Isolation and molecular identification of lactic acid bacteria and Bifidobacterium spp. from faeces of the blue-fronted Amazon parrot in Brazil.
Allegretti L; Revolledo L; Astolfi-Ferreira CS; Chacón JL; Martins LM; Seixas GH; Ferreira AJ
Benef Microbes; 2014 Dec; 5(4):497-503. PubMed ID: 25062609
[TBL] [Abstract][Full Text] [Related]
25. [New Approaches for the Isolation of Bifidobacterial Strains, Their Molecular Characterization, and Assessment of Their Probiotic Potential].
Kharchenko NV; Cherdyntseva TA; Netrusov AI
Mikrobiologiia; 2015; 84(3):352-9. PubMed ID: 26263695
[TBL] [Abstract][Full Text] [Related]
26. Synergistic and antagonistic interactions between antibiotics and synbiotics in modifying the murine fecal microbiome.
Jačan A; Kashofer K; Zenz G; Fröhlich EE; Reichmann F; Hassan AM; Holzer P
Eur J Nutr; 2020 Aug; 59(5):1831-1844. PubMed ID: 31263983
[TBL] [Abstract][Full Text] [Related]
27. Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis.
Satokari RM; Vaughan EE; Akkermans AD; Saarela M; de Vos WM
Appl Environ Microbiol; 2001 Feb; 67(2):504-13. PubMed ID: 11157210
[TBL] [Abstract][Full Text] [Related]
28. Probiotic properties of lactic acid bacteria isolated from stool samples of longevous people in regions of Hotan, Xinjiang and Bama, Guangxi, China.
Gu RX; Yang ZQ; Li ZH; Chen SL; Luo ZL
Anaerobe; 2008 Dec; 14(6):313-7. PubMed ID: 18634896
[TBL] [Abstract][Full Text] [Related]
29. Use of specific primers based on the 16S-23S internal transcribed spacer (ITS) region for the screening Bifidobacterium adolescentis in yogurt products and human stool samples.
Tsai CC; Lai CH; Yu B; Tsen HY
Anaerobe; 2008 Oct; 14(4):219-23. PubMed ID: 18565771
[TBL] [Abstract][Full Text] [Related]
30. Rapid identification of potentially probiotic Bifidobacterium species by multiplex PCR using species-specific primers based on the region extending from 16S rRNA through 23S rRNA.
Kwon HS; Yang EH; Lee SH; Yeon SW; Kang BH; Kim TY
FEMS Microbiol Lett; 2005 Sep; 250(1):55-62. PubMed ID: 16039804
[TBL] [Abstract][Full Text] [Related]
31. Conditions affecting cell surface properties of human intestinal bifidobacteria.
Canzi E; Guglielmetti S; Mora D; Tamagnini I; Parini C
Antonie Van Leeuwenhoek; 2005; 88(3-4):207-19. PubMed ID: 16284927
[TBL] [Abstract][Full Text] [Related]
32. Microbiomic analysis of the bifidobacterial population in the human distal gut.
Turroni F; Marchesi JR; Foroni E; Gueimonde M; Shanahan F; Margolles A; van Sinderen D; Ventura M
ISME J; 2009 Jun; 3(6):745-51. PubMed ID: 19295640
[TBL] [Abstract][Full Text] [Related]
33. In vitro effects of synbiotic fermentation on the canine faecal microbiota.
Ogué-Bon E; Khoo C; McCartney AL; Gibson GR; Rastall RA
FEMS Microbiol Ecol; 2010 Sep; 73(3):587-600. PubMed ID: 20579101
[TBL] [Abstract][Full Text] [Related]
34. Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains.
Strozzi GP; Mogna L
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S179-84. PubMed ID: 18685499
[TBL] [Abstract][Full Text] [Related]
35. Polymerase chain reaction and denaturing gradient gel electrophoresis monitoring of fecal bifidobacterium populations in a prebiotic and probiotic feeding trial.
Satokari RM; Vaughan EE; Akkermans AD; Saarela M; De Vos WM
Syst Appl Microbiol; 2001 Jul; 24(2):227-31. PubMed ID: 11518325
[TBL] [Abstract][Full Text] [Related]
36. A novel multi-strain probiotic and synbiotic supplement for prevention of Clostridium difficile infection in a murine model.
Kondepudi KK; Ambalam P; Karagin PH; Nilsson I; Wadström T; Ljungh Å
Microbiol Immunol; 2014 Oct; 58(10):552-8. PubMed ID: 25059277
[TBL] [Abstract][Full Text] [Related]
37. In vitro effects of selected synbiotics on the human faecal microbiota composition.
Saulnier DM; Gibson GR; Kolida S
FEMS Microbiol Ecol; 2008 Dec; 66(3):516-27. PubMed ID: 18673391
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study.
Ishikawa H; Matsumoto S; Ohashi Y; Imaoka A; Setoyama H; Umesaki Y; Tanaka R; Otani T
Digestion; 2011; 84(2):128-33. PubMed ID: 21525768
[TBL] [Abstract][Full Text] [Related]
39. In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects.
Grimoud J; Durand H; de Souza S; Monsan P; Ouarné F; Theodorou V; Roques C
Int J Food Microbiol; 2010 Nov; 144(1):42-50. PubMed ID: 20951454
[TBL] [Abstract][Full Text] [Related]
40. Microencapsulation of a synbiotic into PLGA/alginate multiparticulate gels.
Cook MT; Tzortzis G; Charalampopoulos D; Khutoryanskiy VV
Int J Pharm; 2014 May; 466(1-2):400-8. PubMed ID: 24657143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
